产品详情 |
Edit |   |
Antigenic Specificity | EGFR |
Clone | monoclonal |
Host Species | Mouse |
Reactive Species | human |
Isotype | IgG1 - kappa |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | ELISA, IP, FC, FuncS, Neut, IF, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-EGFR Therapeutic Antibody (THERACIM (India, China, Cuba, Argentina, Columbia)). Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFR. Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck.Suitable for use in ELISA, IP, FC, FuncS, Neut, IF, IHC and most other immunological methods. |
Immunogen | n/a |
Other Names | nimotuzumab;TheraCIM;780758-10-3;hR3;h-R3;TheraCIM;BIOMAb EGFR;TheraCIM;Theraloc;CIMAher;EGFR;epidermal growth factor receptor;epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) , ERBB;ERBB1;erythroblastic le |
Gene, Accession # | Gene ID: 1956 |
Catalog # | TAB-710 |
Price | |
Order / More Info | EGFR Antibody from CREATIVE BIOLABS |
Product Specific References | n/a |
产品资料 |
|
|